N6-Methyladenosine (m⁶A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma

Figure 5

Survival analysis based on gender, age, stage, and other multiple clinicopathological characteristics between the high-risk and low-risk groups in the entire set. Evaluation of immunotherapy effects and drug screening based on models.

(a)

(b)

(c)

(d)

(e)

(f)